Labiotech.eu

Best in Biotech 24 Oct 2023

Seven molecular glue startups looking to stick around in the biotech industry

Since they were discovered around three decades ago, molecular glues have come a very long way as a therapeutic option for several different disease areas, including cancer and neurodegenerative disorders.…

October 24, 2023 - 9 minutesmins - By Willow Shah-Neville

ODS Paris In vitro 386 Antoine Martel Photographe

Chronic inflammation and cancer: how can preclinical models revolutionize our understanding?

In most cases, chronic inflammation is known to lead to cancer, however, the mechanisms behind this are not fully understood. Preclinical models in immuno-oncology are the first step towards a…

October 24, 2023 - 7 minutesmins - By Alexander Burik

Top 10 tips on how to start an early phase clinical trial

Expert Advice 23 Oct 2023

Top 10 tips from an expert on how to start an early phase clinical trial

Early phase clinical trials can be complicated and time-consuming, with their success dependent on several different factors. The outcome of these early phase clinical trials will determine the future of…

October 23, 2023 - 8 minutesmins - By External Contributor

In Depth 20 Oct 2023

Is Africa ready to become the next big biopharma and vaccine manufacturing destination?

Localizing pharma manufacturing worldwide is an extremely important step, and it holds particular significance for Africa. The continent is more vulnerable to disease burdens and lags behind other continents when…

October 20, 2023 - 10 minutesmins - By Willow Shah-Neville

induced pluripotent stem cells ipsc Alzheimer's

Podcast 20 Oct 2023

Beyond Biotech podcast 68 – rejuvenation with stem cells

This week, our guest on the podcast is Mark Kotter, founder of clock.bio. clock.bio, a sister company to bit.bio, which Kotter also founded and is the CEO of, aims to…

October 20, 2023 - 2 minutesmins - By Jim Cornall

In Depth 19 Oct 2023

Biotech’s battle against NASH: The ongoing pursuit of an effective treatment

NASH is one of the most common reasons for a patients receiving a liver transplant. The condition is a severe form of non-alcoholic fatty liver disease (NAFLD), whereby fat builds…

October 19, 2023 - 8 minutesmins - By Willow Shah-Neville

In Depth 18 Oct 2023

Going nuclear: radiopharmaceuticals see surge in funding

Emerging as a new class of drugs, radiopharmaceuticals are all the rage in cancer treatment research, at present. And now, with American biotech Nucleus RadioPharma raising $56 million to streamline…

October 18, 2023 - 6 minutesmins - By Roohi Mariam Peter

Best in Biotech 17 Oct 2023

Singapore’s biotech scene: six companies leading the way

Singapore set out to become a global biotech hub back in 2000, and, although still awaiting its big success story in the industry, it is currently a leading hub in…

October 17, 2023 - 8 minutesmins - By Willow Shah-Neville

Can we overcome the challenges of bispecific antibody production?

Thanks to their unique features, bispecific antibodies are the fastest-evolving class of biotherapeutics. However, the enormous clinical potential of their unconventional design is accompanied by equally large challenges. How can…

October 17, 2023 - 6 minutesmins - By Ute Boronowsky

In Depth 16 Oct 2023

Blockchain-based biotech: is this a viable financing method?

At a time when biotechs are scrambling to raise funds, a new way for startups to secure investments is emerging: leveraging cryptocurrency. The motive behind decentralized financing seems pretty ambitious…

October 16, 2023 - 10 minutesmins - By Roohi Mariam Peter

In Depth 13 Oct 2023

How close are we to a cure for metastatic breast cancer?

Currently considered an incurable disease, there is a lot of work being done around developing better treatment options for metastatic breast cancer, and, ultimately, a cure. Numerous promising candidates are…

October 13, 2023 - 8 minutesmins - By Willow Shah-Neville

Podcast 13 Oct 2023

Beyond Biotech podcast 67 – natural killer cells

This week, we speak to Artiva Biotherapeutics’ CEO, Fred Aslan, M.D. The company has demonstrated the potential for efficacy and safety with natural killer (NK) cells in two cancer clinical…

October 13, 2023 - 2 minutesmins - By Jim Cornall

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

View all companies A-Z

Partner with world-leading academics working on sustainable materials R&D

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inpart, the leading platform for biopharma partnering